MyMD Pharmaceuticals Inc (MYMD)

[BioFan1]

To summarize for those new to this Board:

1.) MyMD-1 was shown to be effective on Multiple Sclerosis and Hashimoto's Thyroiditis in animal studies at Johns Hopkins University.
2.) Phase 1 human safety trials are complete.
3.) The company holds patents on the use of MyMD-1 to treat virtually all major inflammatory diseases, where billions and billions are spent on pharmaceutical compounds annually.
4.) Big hitters on the MyMD Scientific Advisory Board.
5.) A Pharma Industry insider had loaded up on the the stock out of his own pocket.
6.) Big end-of-day institutional buys the last couple of weeks.
7.) Phase II clinical trials coming soon.
8.) MYMD-1 has no adverse side effects in the animal trials, unlike Humira and the other biologics targeting inflammation.
9.) MYMD-1 is a small molecule that can cross the blood-brain barrier.